Sharon L Manne1, Shannon Myers-Virtue2, David Kissane3,4, Melissa L Ozga3, Deborah A Kashy5, Stephen C Rubin6, Norman G Rosenblum7, Carolyn J Heckman6. 1. Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. 2. Temple University Maurice H. Kornberg School of Dentistry, Philadelphia, Pennsylvania, USA. 3. Memorial Sloan Kettering Cancer Center, New York, New York, USA. 4. Monash University, Clayton, Victoria, Australia. 5. Michigan State University, East Lansing, Michigan, USA. 6. Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. 7. Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Abstract
OBJECTIVE: Fear of cancer recurrence is an important clinical phenomenon and is associated with decrements in life domains. The study goals were to characterize patterns of global fear of recurrence (FOR) and 4 domains of fear (health, role, womanhood, and death worry) over time in women who were diagnosed with gynecological cancer and to identify demographic, medical, and psychological predictors of FOR. METHOD: One hundred eighteen women participating in the usual care arm of a randomized trial completed the Concerns about Recurrence scale as well as measures of depressive symptoms, cancer-specific distress, coping, coping efficacy, and social network responses at 4 time points. The majority of the sample was diagnosed with stage 3 ovarian cancer. RESULTS: Group-based trajectory modeling identified subgroups of women with high-stable (49.1%), high-decreasing (25.3%), and low-stable (25.5%) trajectories for global FOR. For role worries, 3 similar group trajectories were identified. For health worries, modeling identified subgroups with high-decreasing (19.1%) and low-increasing (80.9%) trajectories. For womanhood worries, modeling identified subgroups with high-increasing (15.7%) and low-decreasing (84.2%) trajectories. Young age, metastatic cancer, depression, cancer distress, holding back, and lower coping efficacy were associated with the high-stable global FOR and at least 1 domain of FOR. CONCLUSION: Almost half of the women recently diagnosed with gynecological cancer evidence persistently elevated FOR over the 6-month period postdiagnosis. Psychological interventions to reduce FOR may be more effective if they focus on teaching patients coping skills, as well as greater comfort expressing cancer-specific concerns to others.
RCT Entities:
OBJECTIVE: Fear of cancer recurrence is an important clinical phenomenon and is associated with decrements in life domains. The study goals were to characterize patterns of global fear of recurrence (FOR) and 4 domains of fear (health, role, womanhood, and death worry) over time in women who were diagnosed with gynecological cancer and to identify demographic, medical, and psychological predictors of FOR. METHOD: One hundred eighteen women participating in the usual care arm of a randomized trial completed the Concerns about Recurrence scale as well as measures of depressive symptoms, cancer-specific distress, coping, coping efficacy, and social network responses at 4 time points. The majority of the sample was diagnosed with stage 3 ovarian cancer. RESULTS: Group-based trajectory modeling identified subgroups of women with high-stable (49.1%), high-decreasing (25.3%), and low-stable (25.5%) trajectories for global FOR. For role worries, 3 similar group trajectories were identified. For health worries, modeling identified subgroups with high-decreasing (19.1%) and low-increasing (80.9%) trajectories. For womanhood worries, modeling identified subgroups with high-increasing (15.7%) and low-decreasing (84.2%) trajectories. Young age, metastatic cancer, depression, cancer distress, holding back, and lower coping efficacy were associated with the high-stable global FOR and at least 1 domain of FOR. CONCLUSION: Almost half of the women recently diagnosed with gynecological cancer evidence persistently elevated FOR over the 6-month period postdiagnosis. Psychological interventions to reduce FOR may be more effective if they focus on teaching patients coping skills, as well as greater comfort expressing cancer-specific concerns to others.
Authors: Eileen Huh Shinn; Cindy L Carmack Taylor; Kelly Kilgore; Alan Valentine; Diane C Bodurka; John Kavanagh; Anil Sood; Yisheng Li; Karen Basen-Engquist Journal: Palliat Support Care Date: 2009-09
Authors: Shannon B Myers; Sharon L Manne; David W Kissane; Melissa Ozga; Deborah A Kashy; Stephen Rubin; Carolyn Heckman; Norman Rosenblum; Mark Morgan; John J Graff Journal: Gynecol Oncol Date: 2012-10-23 Impact factor: 5.482
Authors: Sharon L Manne; Deborah A Kashy; David W Kissane; Melissa Ozga; Shannon Myers Virtue; Carolyn J Heckman Journal: Support Care Cancer Date: 2019-08-01 Impact factor: 3.603
Authors: Nina Jackson Levin; Anao Zhang; David Reyes-Gastelum; Debbie W Chen; Ann S Hamilton; Bradley Zebrack; Megan R Haymart Journal: J Cancer Surviv Date: 2021-10-11 Impact factor: 4.062
Authors: Paula Heidkamp; Clara Breidenbach; Kati Hiltrop; Christoph Kowalski; Anna Enders; Holger Pfaff; Birgitta Weltermann; Franziska Geiser; Nicole Ernstmann Journal: Support Care Cancer Date: 2021-06-17 Impact factor: 3.603